Physician profile
John Marson
NPI 1841650843
$3,384.19
in general payments reported to CMS, 2019-2025
12 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,034 · 2020: $23.28 · 2021: $865 · 2022: $904 · 2023: $278 · 2024: $177 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,424.93 | 2021-2025 | Proclaim |
| Nevro Corp. | $490.60 | 2019 | |
| Medtronic, INC. | $446.41 | 2022-2024 | Intellis Adaptivestim, Synchromedii |
| Medtronic USA, INC. | $404.49 | 2019 | |
| Boston Scientific Corporation | $334.18 | 2022-2023 | |
| Biodelivery Sciences International, INC. | $124.99 | 2019 | |
| Fidia Pharma USA INC. | $49.20 | 2021-2023 | Hymovis, Triluron |
| Horizon Therapeutics Plc | $36.60 | 2021-2022 | |
| Ermi LLC | $23.28 | 2020 | |
| Uswm, LLC | $20.75 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.56 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Marson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.